NYSE ARCA | ETF
The fund is an actively managed exchange-traded fund.
The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries.
The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PAGP | Plains GP Holdings LP | Energy | Oil & Gas Midstream | 73.29% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 23.03% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 21.59% |
| PHAT | Phathom Pharmaceuticals Inc | Healthcare | Biotechnology | 14.84% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 14.76% |
| ABEO | Abeona Therapeutics Inc | Healthcare | Biotechnology | 9.41% |
| ARDX | Ardelyx Inc | Healthcare | Biotechnology | 8.31% |
| ACHV | Achieve Life Sciences Inc | Healthcare | Biotechnology | 7.94% |
| TCRX | Tscan Therapeutics Inc | Healthcare | Biotechnology | 7.56% |
| MIST | Milestone Pharmaceuticals Inc | Healthcare | Biotechnology | 5.69% |
| PCJ | ABEONA THERAPEUT. DL-01 | Healthcare | Biotechnology | 4.71% |
| TCRX_old | TCRX | Healthcare | Biotechnology | 4.50% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 4.48% |
| DCTH_old | Delcath Systems Inc | Healthcare | Medical Devices | 4.30% |
| APLT | Applied Therapeutics Inc | Healthcare | Biotechnology | 4.14% |
| KMPH | KemPharm Inc | Healthcare | Pharmaceuticals | 3.84% |
| TSAT | Telesat Corp | Technology | Communication Equipment | 3.71% |
| FULC | Fulcrum Therapeutics Inc | Healthcare | Biotechnology | 3.70% |
| DAWN | Day One Biopharmaceuticals Inc | Healthcare | Biotechnology | 2.76% |
| SNDX | Syndax Pharmaceuticals Inc | Healthcare | Biotechnology | 2.66% |